Foundry Partners, LLC Jazz Pharmaceuticals PLC Transaction History
Foundry Partners, LLC
- $1.92 Billion
- Q4 2024
A detailed history of Foundry Partners, LLC transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Foundry Partners, LLC holds 5,092 shares of JAZZ stock, worth $682,124. This represents 0.03% of its overall portfolio holdings.
Number of Shares
5,092
Previous 3,362
51.46%
Holding current value
$682,124
Previous $374,000
67.65%
% of portfolio
0.03%
Previous 0.02%
Shares
3 transactions
Others Institutions Holding JAZZ
# of Institutions
540Shares Held
59.6MCall Options Held
136KPut Options Held
64K-
Black Rock Inc. New York, NY6.15MShares$823 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.04MShares$809 Million0.01% of portfolio
-
Lsv Asset Management Chicago, IL2.53MShares$339 Million0.72% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.21MShares$297 Million0.67% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.04MShares$273 Million0.06% of portfolio
About Jazz Pharmaceuticals plc
- Ticker JAZZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,680,700
- Market Cap $8.4B
- Description
- Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...